Business Context and Reporting Period
This Form 6-K filing by ZK International Group Co., Ltd. covers the month of February 2021. The report discloses the entry into a material definitive agreement regarding a registered direct offering of securities.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or debt levels. The primary financial data relates to the capital raise transaction:
- Total Investment Amount: $4,599,983.50
- Ordinary Shares Issued: 1,295,770
- First Registered Warrants: 1,295,770 shares at an exercise price of $4.00 per share
- Second Registered Warrants: 1,295,770 shares at an exercise price of $4.50 per share
Material Changes
The material change disclosed is the execution of a Securities Purchase Agreement on February 22, 2021, with several accredited investors. This agreement facilitates the issuance of ordinary shares and two tranches of warrants. The transaction is structured as a registered direct offering under a shelf registration statement (File No. 333-230860) declared effective in April 2019.
Guidance, Outlook, and Risks
Transaction Timeline: The prospectus supplement is expected to be filed on or about February 23, 2021, with the closing of the offering anticipated on or about February 24, 2021, subject to customary conditions.
Forward-Looking Statements: The filing includes standard disclaimers that forward-looking statements involve risks and uncertainties. Actual results may differ materially due to factors discussed in the Company's Annual Report on Form 20-F for the year ended September 30, 2020.
Investor Status: The investors are accredited and purchased securities for investment purposes, not for distribution. No general solicitation or advertising was used.
Investor Verification Checklist
- Verify the final closing date of the offering and the actual proceeds received.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific covenants and conditions.
- Confirm the effectiveness of the prospectus supplement filed with the SEC.
- Assess the dilution impact of the 1,295,770 new shares and the potential exercise of 2,591,540 warrant shares.
- Check the Company's Form 20-F for the year ended September 30, 2020, for detailed risk factors and historical financial performance.